Literature DB >> 31004441

Navigating the Labyrinth of Pharmacogenetic Testing: A Guide to Test Selection.

Chad A Bousman1,2,3, Heather Zierhut4, Daniel J Müller5,6.   

Abstract

Mesh：

Year:  2019        PMID： 31004441     DOI： 10.1002/cpt.1432

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  16 in total

1.  Pharmacogenetics: Chasing Perfection.

Authors:  Andrea Gaedigk
Journal:  Clin Pharmacol Ther       Date:  2019-08       Impact factor: 6.875

2.  Implementation and obstacles of pharmacogenetics in clinical practice: An international survey.

Authors:  Elizabeth Abou Diwan; Ralph I Zeitoun; Lea Abou Haidar; Ingolf Cascorbi; Nathalie Khoueiry Zgheib
Journal:  Br J Clin Pharmacol       Date:  2019-07-07       Impact factor: 4.335

Review 3.  Pharmacogenetic Testing Options Relevant to Psychiatry in Canada: Options de tests pharmacogénétiques pertinents en psychiatrie au Canada.

Authors:  Abdullah Al Maruf; Mikayla Fan; Paul D Arnold; Daniel J Müller; Katherine J Aitchison; Chad A Bousman
Journal:  Can J Psychiatry       Date:  2020-02-17       Impact factor: 4.356

4.  Pharmacogenetic Testing Knowledge and Attitudes among Pediatric Psychiatrists and Pediatricians in Alberta, Canada.

Authors:  Chaten D Jessel; Abdullah Al Maruf; Anita Oomen; Paul D Arnold; Chad A Bousman
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2022-02-01

5.  Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2021-08-12

6.  Pharmacogenetics: A Precision Medicine Approach to Combatting the Opioid Epidemic.

Authors:  D Max Smith; James M Stevenson; Teresa T Ho; Christine M Formea; Roseann S Gammal; Larisa H Cavallari
Journal:  J Am Coll Clin Pharm       Date:  2021-12-19

Review 7.  PharmVar GeneFocus: CYP2D6.

Authors:  Charity Nofziger; Amy J Turner; Katrin Sangkuhl; Michelle Whirl-Carrillo; José A G Agúndez; John L Black; Henry M Dunnenberger; Gualberto Ruano; Martin A Kennedy; Michael S Phillips; Houda Hachad; Teri E Klein; Andrea Gaedigk
Journal:  Clin Pharmacol Ther       Date:  2019-12-09       Impact factor: 6.875

8.  Estimating the Potential Impact of CYP2C19 and CYP2D6 Genetic Testing on Protocol-Based Care for Depression in Canada and the United States.

Authors:  Mikayla Fan; Chad A Bousman
Journal:  Mol Neuropsychiatry       Date:  2019-11-26

Review 9.  PharmVar GeneFocus: CYP2C19.

Authors:  Mariana R Botton; Michelle Whirl-Carrillo; Andria L Del Tredici; Katrin Sangkuhl; Larisa H Cavallari; José A G Agúndez; Jorge Duconge; Ming Ta Michael Lee; Erica L Woodahl; Karla Claudio-Campos; Ann K Daly; Teri E Klein; Victoria M Pratt; Stuart A Scott; Andrea Gaedigk
Journal:  Clin Pharmacol Ther       Date:  2020-07-22       Impact factor: 6.875

Review 10.  PharmVar GeneFocus: CYP2C9.

Authors:  Katrin Sangkuhl; Karla Claudio-Campos; Larisa H Cavallari; Jose A G Agundez; Michelle Whirl-Carrillo; Jorge Duconge; Andria L Del Tredici; Mia Wadelius; Mariana Rodrigues Botton; Erica L Woodahl; Stuart A Scott; Teri E Klein; Victoria M Pratt; Ann K Daly; Andrea Gaedigk
Journal:  Clin Pharmacol Ther       Date:  2021-07-12       Impact factor: 6.903
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.